|
2024
|
Invention
|
Heteroaryl and heterocyclic compounds for treating acute inflammation.
The present disclosure re... |
|
|
Invention
|
Heteroaryl and heterocyclic compounds for use in treating acute inflammation. The present disclos... |
|
2023
|
Invention
|
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase. + biosynthesis, e.... |
|
|
Invention
|
Pyrimidinone compounds for treating acute inflammation.
The present disclosure relates to a meth... |
|
|
Invention
|
Pyrimidinone compounds for treating acute inflammation |
|
|
Invention
|
Pyrimidinone compounds for treating acute inflammation. The present disclosure relates to a metho... |
|
2021
|
Invention
|
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase.
The present discl... |
|
|
Invention
|
Heterocyclic compounds for modulating nr2f6.
The present disclosure relates to compounds capable... |
|
|
Invention
|
Heterocyclic compounds for modulating nr2f6. The present disclosure relates to compounds capable ... |
|
2020
|
Invention
|
Compounds and compositions for the treatment of tumors.
The present invention relates to compoun... |
|
|
Invention
|
Compounds and compositions for the treatment of tumors. The present invention relates to compound... |
|
2019
|
Invention
|
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxxylase. The present discl... |
|
|
Invention
|
Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase. The present disclosure di... |
|
2017
|
Invention
|
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase. The present disclo... |
|
2015
|
Invention
|
Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase. + biosynthesis, e.g., met... |
|
|
Invention
|
Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-se... |
